Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04837105 |
|
Recruitment Status :
Recruiting
First Posted : April 8, 2021
Last Update Posted : December 9, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Cerebral palsy (CP) is defined as a group of movement and posture disorders that cause activity limitation due to brain damage during fetal development or in the first year of life. Motor activities, and in particular walking, can be affected by many factors including sensory deficits, biomechanical and postural limitations, muscle weakness and spasticity. Theories of gait training guide rehabilitation management strategies. Among these, intensification, variability and specific training of walking parameters (speed, step length, cadence) have shown their effectiveness. Delivering sensory feedback during gait rehabilitation exercises is a complementary approach to improve motor learning during rehabilitation. On the other hand, motivation is a key factor in the success of rehabilitation. The addition of walking exercises performed through a serious game in augmented reality (AR) appears relevant for the rehabilitation of children with CP after surgery.
The serious game ARRoW-CP is based on the latest advances in the literature in terms of gait rehabilitation protocol but also on the results of a clinical study conducted by our team, to identify the best feedback modalities to be delivered during the serious rehabilitation game.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cerebral Palsy Gait Disorders, Neurologic | Other: Serious game ARROW CP Other: Treadmill | Not Applicable |
This study is a randomized control trial.
Participants are children with cerebral palsy having a single event multi level surgery. They are involving in a rehabilitation protocol in the same rehab center.
Two groups are formed:
- control group: classic rehab+children have treadmill gait protocol during 4 weeks
- test group : classic rehab+children have gait training with the ARROW CP serious game.
ARROW CP game is developed for augmented reality headset (Microsoft Hololens). It delivers feedback in real time and with delay on participant gait performance. This game has been developed by researchers (Fondation Ellen Poidatz, France).
The aims of this study are:
- . To determine the impact on spatiotemporal gait parameters of intensive gait rehabilitation involving the use of a serious AR game in children and adolescents with cerebral palsy.
- To explore the effects of playing a serious game on functional abilities
- To assess motivation, satisfaction and adherence to treatment
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | randomized control trial - 2 groups |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Pre-test and post-test evaluation are made by one physiotherapist ignoring the patient's arm. |
| Primary Purpose: | Treatment |
| Official Title: | Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy: Randomized Control Trial |
| Actual Study Start Date : | April 15, 2021 |
| Estimated Primary Completion Date : | June 2022 |
| Estimated Study Completion Date : | December 31, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Control group
Classic rehab (physio including strength rehab, fitness, motor activity...) + treadmill gait training 3*/week/4weeks: 5 minutes of warm-up with gradual increase in treadmill speed, max 20 minutes of walking at 80% of maximum speed, 5 minutes of active recovery with gradual decrease in treadmill speed. (protocol from Grecco et al.) |
Other: Treadmill
Participant walk on a treadmill at 80% of their maximal speed during maximum 20 minutes |
|
Experimental: Test group
Classic rehab - same as control group - (physio including strength rehab, fitness, motor activity...) + overground ARROW CP gait training 3*/week/4weeks: walking sprint session at maximal speed with gradual increase in number of repetitions over the weeks. (protocol from Verschuren et al.) |
Other: Serious game ARROW CP
ARROW CP is developed for Microsoft Hololens headset. Feedback on gait performance are delivering to the participant in real time and with delay. Participants have to walk at their maximal speed during "sprint session". |
- 6 minutes walking test [ Time Frame: 6 minutes ]
Aim of the measurement: To quantify changes in the parameters of walking quality (speed, cadence, step length).
Procedure: The patient is instructed to walk for 6 minutes in an unobstructed corridor. The distance walked is recorded for the calculation of walking speed. Fatigue is assessed with a Borg scale and heart rate is continuously recorded.
- Muscle power sprint test [ Time Frame: 10 minutes ]
Aim of the measurement: To assess the anaerobic capacity of children with motor disabilities.
Procedure: The patient is asked to perform six 15-metre walking sprints, with 10 seconds of rest between each sprint. The average and maximum power are calculated based on the speeds achieved during the sprints.
- Shuttle run test I and II (adapted for children with CP) [ Time Frame: 20 minutes ]
In this test, the child must walk between 2 poles spaced 10 metres apart following the "beep rhythm" imposed by a pre-recorded soundtrack. The soundtrack includes an increase in walking speed of 0.25 km/h every minute.
(Verschuren et al.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 10 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- A clinical diagnosis of CP mentioned in the medical record
- Minor child for the entire duration of the protocol, i.e. between 10 and 17 years of age (the child must be less than 18 years of age at the time of the last check-up scheduled 1 year after inclusion in the study)
- Global Motor Function Classification System (GMFCS) levels I to III
- Ability to cooperate, understand and follow simple instructions to play.
- Patient affiliated to the French social security system
- Voluntary patient whose parents have given their consent for their child to participate in the study
- Patient who has undergone multisite surgery of the lower limbs including bone procedures at least 7 weeks before the start of the procedure
Exclusion Criteria:
- A diagnosis of photosensitive epilepsy mentioned in the medical file AND/OR a mention in the child's medical file or by the parents or by the child of a history of epileptic seizures occurring during the practice of a video game
- A visual, cognitive or auditory impairment at a level that would interfere with playing the game. The patient must have normal or corrected vision and hearing.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04837105
| France | |
| Fondation Ellen Poidatz | Recruiting |
| Saint-Fargeau-Ponthierry, ILE DE France, France, 77310 | |
| Contact: Eric Desailly, PhD 160652765 ext +33 eric.desailly@fondationpoidatz.com | |
| Responsible Party: | Fondation Ellen Poidatz |
| ClinicalTrials.gov Identifier: | NCT04837105 |
| Other Study ID Numbers: |
ARROW CP |
| First Posted: | April 8, 2021 Key Record Dates |
| Last Update Posted: | December 9, 2021 |
| Last Verified: | November 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
physiotherapy gait rehabilitation serious game multi level surgery |
|
Cerebral Palsy Nervous System Diseases Gait Disorders, Neurologic Neurologic Manifestations |
Brain Damage, Chronic Brain Diseases Central Nervous System Diseases |

